These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 9200290)

  • 1. Hereditary non-polyposis colorectal cancer: clinical features and survival. Results from the Danish HNPCC register.
    Myrhøj T; Bisgaard ML; Bernstein I; Svendsen LB; Søndergaard JO; Bülow S
    Scand J Gastroenterol; 1997 Jun; 32(6):572-6. PubMed ID: 9200290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival of patients with Stage III colon cancer is improved in hereditary non-polyposis colorectal cancer compared with sporadic cases. A Danish registry based study.
    Brixen LM; Bernstein IT; Bülow S; Ehrnrooth E
    Colorectal Dis; 2013 Jul; 15(7):816-23. PubMed ID: 23350633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Registration of hereditary non-polyposis colorectal cancer].
    Bernstein IT; Bisgaard ML; Myrhøj T
    Ugeskr Laeger; 1999 Nov; 161(45):6174-8. PubMed ID: 10603753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival of hereditary non-polyposis colorectal cancer patients compared with sporadic colorectal cancer patients.
    Stigliano V; Assisi D; Cosimelli M; Palmirotta R; Giannarelli D; Mottolese M; Mete LS; Mancini R; Casale V
    J Exp Clin Cancer Res; 2008 Sep; 27(1):39. PubMed ID: 18803843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of survival between patients with hereditary non polyposis colorectal cancer (HNPCC) and sporadic colorectal cancer.
    Haghighi MM; Vahedi M; Mohebbi SR; Pourhoseingholi MA; Fatemi SR; Zali MR
    Asian Pac J Cancer Prev; 2009; 10(2):209-12. PubMed ID: 19537885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival of patients with hereditary colorectal cancer: comparison of HNPCC and colorectal cancer in FAP patients with sporadic colorectal cancer.
    Bertario L; Russo A; Sala P; Eboli M; Radice P; Presciuttini S; Andreola S; Rodriguez-Bigas MA; Pizzetti P; Spinelli P
    Int J Cancer; 1999 Jan; 80(2):183-7. PubMed ID: 9935197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prevention of colorectal cancer in families with hereditary nonpolyposis colorectal cancer].
    Bernstein IT; Bisgaard ML; Myrhøj T
    Ugeskr Laeger; 2003 Jan; 165(3):221-5. PubMed ID: 12555703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colorectal carcinoma survival among hereditary nonpolyposis colorectal carcinoma family members.
    Watson P; Lin KM; Rodriguez-Bigas MA; Smyrk T; Lemon S; Shashidharan M; Franklin B; Karr B; Thorson A; Lynch HT
    Cancer; 1998 Jul; 83(2):259-66. PubMed ID: 9669808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hereditary colorectal cancer].
    Bernstein IT; Bülow S
    Ugeskr Laeger; 2005 Oct; 167(44):4159-63. PubMed ID: 16266567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical implications of recognition of the hereditary non-polyposis colon cancer syndrome (HNPCC) for the early detection of colorectal cancer.
    Jablonská M; Rezníková L; Kotrlík J; Svitavský M; Miková M; Tabach J
    Sb Lek; 1995; 96(3):275-82. PubMed ID: 8718819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognosis of colorectal cancer varies in different high-risk conditions.
    Aarnio M; Mustonen H; Mecklin JP; Järvinen HJ
    Ann Med; 1998 Feb; 30(1):75-80. PubMed ID: 9556092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival from colorectal carcinoma in HNPCC families as compared to the general population in Lithuania--initial results.
    Elsakov P; Kurtinaitis J
    Fam Cancer; 2006; 5(4):369-71. PubMed ID: 16826317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival analysis in families affected by hereditary non-polyposis colorectal cancer.
    Percesepe A; Benatti P; Roncucci L; Sassatelli R; Fante R; Ganazzi D; Bellacosa A; Genuardi M; Neri G; Viel A; Ponz de Leon M
    Int J Cancer; 1997 May; 71(3):373-6. PubMed ID: 9139871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Varying features of early age-of-onset "sporadic" and hereditary nonpolyposis colorectal cancer patients.
    Guillem JG; Puig-La Calle J; Cellini C; Murray M; Ng J; Fazzari M; Paty PB; Quan SH; Wong WD; Cohen AM
    Dis Colon Rectum; 1999 Jan; 42(1):36-42. PubMed ID: 10211518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinction of hereditary nonpolyposis colorectal cancer and sporadic microsatellite-unstable colorectal cancer through quantification of MLH1 methylation by real-time PCR.
    Bettstetter M; Dechant S; Ruemmele P; Grabowski M; Keller G; Holinski-Feder E; Hartmann A; Hofstaedter F; Dietmaier W
    Clin Cancer Res; 2007 Jun; 13(11):3221-8. PubMed ID: 17545526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inverse effects of mucin on survival of matched hereditary nonpolyposis colorectal cancer and sporadic colorectal cancer patients.
    You JF; Hsieh LL; Changchien CR; Chen JS; Chen JR; Chiang JM; Yeh CY; Hsieh PS; Fan CW; Liu CT; Tang R
    Clin Cancer Res; 2006 Jul; 12(14 Pt 1):4244-50. PubMed ID: 16857798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Promoter hypermethylation frequency and BRAF mutations distinguish hereditary non-polyposis colon cancer from sporadic MSI-H colon cancer.
    McGivern A; Wynter CV; Whitehall VL; Kambara T; Spring KJ; Walsh MD; Barker MA; Arnold S; Simms LA; Leggett BA; Young J; Jass JR
    Fam Cancer; 2004; 3(2):101-7. PubMed ID: 15340260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simplified MSI marker panel for diagnosis of colorectal cancer.
    Shemirani AI; Haghighi MM; Zadeh SM; Fatemi SR; Taleghani MY; Zali N; Akbari Z; Kashfi SM; Zali MR
    Asian Pac J Cancer Prev; 2011; 12(8):2101-4. PubMed ID: 22292659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of cancer revealed by follow-up of families with hereditary non-polyposis colorectal cancer: a population-based study.
    Ponz de Leon M; Benatti P; Pedroni M; Sassatelli R; Roncucci L
    Int J Cancer; 1993 Sep; 55(2):202-7. PubMed ID: 8370616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival of patients with ovarian cancer due to a mismatch repair defect.
    Crijnen TE; Janssen-Heijnen ML; Gelderblom H; Morreau J; Nooij MA; Kenter GG; Vasen HF
    Fam Cancer; 2005; 4(4):301-5. PubMed ID: 16341807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.